HLscience Statistics

Total Valuation

HLscience has a market cap or net worth of KRW 63.66 billion. The enterprise value is 38.07 billion.

Market Cap	63.66B
Enterprise Value	38.07B

Important Dates

The next estimated earnings date is Tuesday, March 18, 2025.

Earnings Date	Mar 18, 2025
Ex-Dividend Date	n/a

Share Statistics

HLscience has 5.09 million shares outstanding. The number of shares has decreased by -0.54% in one year.

Current Share Class	n/a
Shares Outstanding	5.09M
Shares Change (YoY)	-0.54%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	66.97%
Owned by Institutions (%)	n/a
Float	1.68M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.23
PB Ratio	0.65
P/TBV Ratio	0.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.22
EV / Sales	1.93
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.72

Financial Position

The company has a current ratio of 18.46, with a Debt / Equity ratio of 0.00.

Current Ratio	18.46
Quick Ratio	15.45
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	-0.07
Interest Coverage	-910.44

Financial Efficiency

Return on equity (ROE) is -4.16% and return on invested capital (ROIC) is -4.59%.

Return on Equity (ROE)	-4.16%
Return on Assets (ROA)	-4.48%
Return on Capital (ROIC)	-4.59%
Revenue Per Employee	273.55M
Profits Per Employee	-57.32M
Employee Count	72
Asset Turnover	0.19
Inventory Turnover	1.62

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -21.28% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-21.28%
50-Day Moving Average	14,061.80
200-Day Moving Average	14,112.25
Relative Strength Index (RSI)	44.16
Average Volume (20 Days)	18,752

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HLscience had revenue of KRW 19.70 billion and -4.13 billion in losses. Loss per share was -810.40.

Revenue	19.70B
Gross Profit	11.36B
Operating Income	-7.41B
Pretax Income	-5.66B
Net Income	-4.13B
EBITDA	-4.88B
EBIT	-7.41B
Loss Per Share	-810.40

Full Income Statement

Balance Sheet

The company has 26.15 billion in cash and 450.00 million in debt, giving a net cash position of 25.70 billion or 5,045.21 per share.

Cash & Cash Equivalents	26.15B
Total Debt	450.00M
Net Cash	25.70B
Net Cash Per Share	5,045.21
Equity (Book Value)	98.61B
Book Value Per Share	19,342.98
Working Capital	33.31B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.32 billion and capital expenditures -1.34 billion, giving a free cash flow of -6.66 billion.

Operating Cash Flow	-5.32B
Capital Expenditures	-1.34B
Free Cash Flow	-6.66B
FCF Per Share	-1,307.16

Full Cash Flow Statement

Margins

Gross margin is 57.68%, with operating and profit margins of -37.62% and -20.96%.

Gross Margin	57.68%
Operating Margin	-37.62%
Pretax Margin	-28.76%
Profit Margin	-20.96%
EBITDA Margin	-24.77%
EBIT Margin	-37.62%
FCF Margin	n/a

Dividends & Yields

HLscience does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.54%
Shareholder Yield	0.54%
Earnings Yield	-6.48%
FCF Yield	-10.46%

Dividend Details

Stock Splits

The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.05.

Last Split Date	Dec 29, 2020
Split Type	Forward
Split Ratio	1.05

Scores

HLscience has an Altman Z-Score of 18.08.

Altman Z-Score	18.08
Piotroski F-Score	n/a